Tag: Mercy BioAnalytics

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs

Mercy BioAnalytics Announces $59 Million Series B Financing to Advance Early Cancer Detection Programs

WALTHAM, Mass., Sept. 3, 2025 /PRNewswire/ — Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced the closing of a $59 million series B financing. The round was co-led by…

Read More Read More

Mercy BioAnalytics has filed a notice of an exempt offering of securities to raise $41,000,000.00 in New Equity Investment.

Mercy BioAnalytics has filed a notice of an exempt offering of securities to raise $41,000,000.00 in New Equity Investment.

According to filings with the U.S. Securities and Exchange Commission, Mercy BioAnalytics is raising $41,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Dawn Mattoon played a key role…

Read More Read More